|George Washington University School of Medicine|
|City: Washington||State: DC|
George Washington University School of Medicine indicated in correspondence that they are in the process of revising their current COI policies. However, at the time of release of the 2011-12 AMSA PharmFree Scorecard, these policies were not yet approved. The following commentary and grades reflect the currently active policy.
This institution provided a policy for faculty conduct including only disclosure provisions. Polices governing the affiliated pediatric hospital were submitted in addition, but do not affect enough faculty, staff and trainees to represent a comprehensive policy. However, these Children’s National Medical Center (CNMC) policies are strong in many domains. CNMC suggests it has additional policies regarding the conduct with pharmaceutical sales representatives, but the Scorecard was not provided those policies.
This institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard. This institution's evaluation was last updated: 12/05/2010
This institution has not indicated consent to allow their policy to be publicly posted or quoted for illustrative purposes.
|Gifts & Meals||This policy cites adherence to AMA standards, which does not constitute a meaningful limit on meals or gifts from pharmaceutical and medical device companies. [For the Children’s National Medical Center (CNMC), no meals, gifts, sports tickets are permitted]|
|Consulting relationships||This policy requires that faculty who enter into consulting agreements must make them independent of the university setting. The institution places no substantive approval processes or limits on consulting arrangements [Although the CNMC has good consulting regulations requiring a written contract for fair market value and legitimate services only, with prior review by the legal department].|
|Industry-funded speaking relationships||Regulation of speaking relationships is not addressed by the medical school. [CNMC explicitly prohibits Speaker's Bureaus except for "exceptional circumstances," for which prior written approval must be garnered]|
|Disclosure||The institution requires that only full-time faculty make disclosures.|
|Pharmaceutical samples||The sole samples policy provided was a CNMC policy stating samples "must be processed through the pharmacy and utilize a specific policy and procedure about their distribution”|
|Purchasing & Formularies||A policy clearly applicable to purchasing and formulary decisions was not provided.|
|Industry Sales Representatives||The sole policy covering site-access by industry representatives was a CNMC policy.|
|On-campus Education||Whether the medical school extends the ACCME standards for commercial support to non-accredited education programs is unclear but implied.|
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||No medical school policy related to attendance at off-site educational events was provided.|
|Industry Support for Scholarships & Funds for Trainees||The medical school policy mentions that pharma reps should not have interaction with trainees, but does not place limits on the funding of trainees by industry.|
|Medical school curriculum||A detailed curriculum on pharmaceutical industry influence on prescribing was provided.|
|Do the policies specify an oversight mechanism?||A compliance officer is responsible for policy adherence and reports to the compliance committee.|
|Are there explicit sanctions for noncompliance?||Sanctions referenced.|
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|